ARID2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.342000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.802800E-01
Normal-vs-Stage2
2.342000E-01
Normal-vs-Stage3
1.546150E-02
Normal-vs-Stage4
7.441800E-01
Stage1-vs-Stage2
5.743200E-01
Stage1-vs-Stage3
7.047800E-02
Stage1-vs-Stage4
7.938000E-01
Stage2-vs-Stage3
1.117980E-01
Stage2-vs-Stage4
4.142400E-01
Stage3-vs-Stage4
1.061210E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.203200E-01
Normal-vs-AfricanAmerican
5.936800E-01
Normal-vs-Asian
2.296600E-01
Caucasian-vs-AfricanAmerican
4.726200E-01
Caucasian-vs-Asian
5.569000E-01
AfricanAmerican-vs-Asian
4.182400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.406600E-01
Normal-vs-Female
2.410000E-01
Male-vs-Female
6.553800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.331800E-01
Normal-vs-Age(41-60Yrs)
5.439000E-01
Normal-vs-Age(61-80Yrs)
1.395800E-01
Normal-vs-Age(81-100Yrs)
1.847450E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.096800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.327400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.884400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.675100E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.817500E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.771000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.353040E-01
Normal-vs-Daily Drinker
5.796100E-02
Normal-vs-Weekly Drinker
1.759560E-01
Normal-vs-Occasional Drinker
3.769400E-01
Normal-vs-Social Drinker
3.687200E-01
Non Drinker-vs-Daily Drinker
3.745600E-01
Non Drinker-vs-Weekly Drinker
7.752200E-01
Non Drinker-vs-Occasional Drinker
2.332800E-01
Non Drinker-vs-Social Drinker
3.002200E-01
Daily Drinker-vs-Weekly Drinker
6.765800E-01
Daily Drinker-vs-Occasional Drinker
5.729500E-02
Daily Drinker-vs-Social Drinker
8.558200E-02
Weekly Drinker-vs-Occasional Drinker
2.391200E-01
Weekly Drinker-vs-Social Drinker
2.949600E-01
Occasional Drinker-vs-Social Drinker
9.393600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.562100E-02
Normal-vs-Grade 2
1.947700E-02
Normal-vs-Grade 3
9.417300E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.627200E-01
Grade 1-vs-Grade 3
8.846800E-01
Grade 1-vs-Grade 4
4.562100E-02
Grade 2-vs-Grade 3
3.440800E-01
Grade 2-vs-Grade 4
1.947700E-02
Grade 3-vs-Grade 4
9.417300E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.033230E-01
Normal-vs-NonDiabetic
1.606210E-01
Diabetic-vs-NonDiabetic
5.460400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.072200E-02
Normal-vs-NoPancreatitis
1.702590E-01
Pancreatitis-vs-NoPancreatitis
1.721810E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.533600E-01
Normal-vs-N1
2.417400E-01
N0-vs-N1
7.720600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.906000E-01
Normal-vs-TP53-NonMutant
5.423400E-01
TP53-Mutant-vs-TP53-NonMutant
2.025000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
